Procedures

WWARN is continually updating a library of standardised procedures that offer guidance in the execution of various activities in the fields of clinical, in vitro, pharmacology, data collection and molecular analysis for antimalarial drug resistance researchers. Please read our tools and resources usage guidance.

For resources that relate to other infectious and emerging diseases, visit iddo.org.

Publication Code: PHA08

These guidelines aim to standardize the sample collection procedure during clinical studies of piperaquine antimalarial drugs

Version: 1.0

Publication Code: CL15

A process for collecting and sampling for urine pharmacokinetic measurements in clinical trials

Version: 2.0

Publication Code: CL02

A process for measurement and recording of axillary body temperature of participants enrolled in malaria drug trials

Version: 2.0

Publication Code: CL17

These guidelines aim to standardize the sample collection procedure during clinical studies of pyronaridine antimalarial drugs

Version: 2.0

Publication Code: QA10

A process for when the trial site arranges the initiation meeting/visit for a trial

Version: 2.0

Publication Code: AD12

A process for archiving Essential Documents generated during a malaria clinical trial

Version: 2.0

Publication Code: AD13

A suggested process for communicating end of trial results to people who took part in a typical antimalarial drug trial

Version: v1.0

Publication Code: QA08

For when an investigator/institution takes responsibility for on-site monitoring of a clinical trial

Version: 2.0

Publication Code: AD02

A process for sites for generating important documents and a systematic filing system

Version: 2.0

These are template database tables for use in a typical malaria efficacy trial analysis

Version: v2.0